S&S Healthcare Holding Ltd.

4198 · TWO · Healthcare / Medical Devices

48.00TWD+1.25 (+2.67%)

Price History

Full chart

Market Stats

Previous Close46.75

Open48.00

Day Range45.45 – 48.00

52-Week Range29.95 – 52.50

Volume12.40K

Market Cap1.18B

P/E (TTM)0.00

Forward P/E0.00

EPS-1.67

Dividend Yield0.00%

Beta0.41

50-Day Avg45.09

200-Day Avg39.41

About

S&S Healthcare Holding Ltd. focuses on the research and development, manufacture, and sales of medical imaging devices in Taiwan, the United States, Switzerland, and internationally. It develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd. and changed its name to S&S Healthcare Holding Ltd. in August 2020. S&S Healthcare Holding Ltd. was founded in 1988 and is headquartered in Taipei, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Tien-Ying Lee
Employees0
HeadquartersNo. 85 Xinhu 1st Road, Taipei, Taiwan, 114, Taiwan
Websitehttps://www.swissray.com

Leadership

Mr. Tien-Ying LeeCOO & Director
Guo-Dong LinManager
Yuxiang HuangAccounting Supervisor

Financials

Income Statement

Currency: TWD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	181.73M	101.36M	122.35M	254.44M	254.52M	240.25M	204.21M
Growth (%)	-	-44.22%	+20.71%	+107.95%	+0.03%	-5.61%	-15.00%
Cost of Revenue	167.12M	124.76M	130.29M	216.05M	218.87M	165.24M	137.10M
Gross Profit	14.61M	-23.40M	-7.93M	38.39M	35.66M	75.01M	67.11M
Gross Margin	8.04%	-23.09%	-6.48%	15.09%	14.01%	31.22%	32.86%
Operating Expense	145.44M	109.65M	95.93M	135.30M	127.01M	143.43M	114.34M
Operating Income	-130.83M	-133.05M	-103.87M	-96.91M	-91.36M	-68.42M	-47.23M
Operating Margin	-71.99%	-131.27%	-84.89%	-38.09%	-35.89%	-28.48%	-23.13%
EBITDA	-123.69M	-93.47M	-71.64M	-33.61M	133.81M	-17.60M	-27.87M
EBITDA Margin	-68.06%	-92.22%	-58.55%	-13.21%	52.57%	-7.32%	-13.65%
Net Income	-152.38M	-114.86M	-95.39M	-66.89M	103.61M	-41.28M	-47.30M
Net Income Margin	-83.85%	-113.32%	-77.97%	-26.29%	40.71%	-17.18%	-23.16%
R&D	34.44M	36.17M	24.33M	21.38M	15.11M	10.04M	8.89M
R&D as % of Total Revenue	18.95%	35.68%	19.88%	8.40%	5.94%	4.18%	4.35%
Interest Expense	2.08M	1.92M	1.74M	2.37M	5.24M	2.17M	1.03M
Interest Expense % of Total Revenue	1.15%	1.90%	1.42%	0.93%	2.06%	0.90%	0.50%

Balance Sheet

Currency: TWD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	297.93M	288.13M	294.12M	531.06M	613.34M	433.83M	377.06M
Total Liabilities	197.97M	220.34M	199.92M	315.64M	209.24M	116.24M	100.37M
Total Equity	99.96M	67.79M	54.99M	135.25M	300.74M	260.85M	226.50M
Cash	48.68M	94.68M	121.88M	112.32M	198.99M	150.02M	106.85M
Total Debt	-	139.81M	124.06M	183.91M	88.08M	-	-
Net Debt	-48.68M	45.13M	2.18M	71.58M	-110.91M	-	-

Cash Flow

Currency: TWD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-89.40M	-58.62M	-70.52M	-72.91M	-68.10M	-41.89M	-26.66M
Capital Expenditure	790.00K	9.75M	9.84M	69.17M	31.15M	19.07M	3.52M
Free Cash Flow	-90.19M	-68.38M	-80.36M	-142.07M	-99.25M	-60.96M	-30.18M
FCF to OCF	100.88%	116.64%	113.95%	194.87%	145.74%	145.51%	113.21%

Earnings

Report Date	May 15, 2015	Mar 31, 2017	May 10, 2017
EPS Estimate	-17.83	-11.67	-11.00
EPS Actual	-21.00	-15.45	-15.17
Surprise	-17.78%	-32.39%	-37.91%
Timing	Pre-market	After-hours	Pre-market

Key Statistics & Ratios

Market Cap1.18B

Enterprise Value1.14B

Trailing P/E0.00

Forward P/E0.00

Price / Sales6.85

Price / Book5.84

EPS-1.67

Book Value8.46

Revenue (TTM)172.45M

Gross Profit (TTM)57.98M

EBITDA-37.36M

Profit Margin-23.47%

Operating Margin-44.25%

Return on Equity-15.69%

Return on Assets-8.79%

Shares Outstanding24.11M

Shares Float4.37M

Beta0.41

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Aug 4, 2022200:1000
Aug 16, 2018300:1000